All companies
Visit website
MYFLORADNA
OperatingMyFloraDNA Inc.
Healthcare · Founded 2019
Making peanuts allergy-free
Post-money valuation ⓘ
$17.6M
As of Oct 2024 · from MyFloraDNA Common Stock 1 · pre-money + amount raised, not a traded price
Total raised
$8,185
Across 1 round since 2024
Latest share price
$6.44
MyFloraDNA Common Stock 1 offering price
Financials
FY2022–FY2023 · from SEC filings · hover any figure for its source$1.1M
−$216K
2022
$2.8M
−$35K
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022
FY2023
Income statement
Revenue
$1,097,372
$2,780,074
Cost of goods sold
$209,704
$422,731
Gross margin
81%
85%
Net income
-$216,003
-$34,629
Taxes paid
$0
$0
Balance sheet
Cash
$464,535
$407,060
Accounts receivable
$208,773
$370,066
Total assets
$705,265
$895,139
Short-term debt
$86,271
$199,653
Long-term debt
$895,500
$101,853
Total liabilities
$981,771
$301,506
Other
Headcount
—
10
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$17.6M
post-money
MyFloraDNA Common Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $8.2K / $1.2MInvestors 17Post-money $17.6M
Reg CF annual-report compliance
Not obligated
never closed a Reg CF raise
17 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001935334Share price $6.44
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.